INS and type 2 diabetes mellitus: In our exploratory pilot cohort of ICU patients with type 2 diabetes managed according to a liberal glucose control protocol, treatment with empagliflozin reduced insulin requirements and was associated with a significantly greater increase in sodium and chloride levels and urinary output.